Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Astrocytic lipid dysregulation as an early driver of neurodegeneration.

Nature reviews. Neurology·2026
Same author

CRYAB is compromised in pathologically affected oligodendrocytes in multiple system atrophy.

Brain pathology (Zurich, Switzerland)·2026
Same author

Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour Disorder.

Brain, behavior, & immunity - health·2026
Same author

Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease.

Human molecular genetics·2026
Same author

Location and mapping of the human rostromedial tegmental nucleus and associated midbrain inhibitory nuclei regulating dopamine neurons.

Brain structure & function·2026
Same author

Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum.

FEBS open bio·2026

Related Experiment Video

Updated: Mar 26, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.5K

Animal modeling an oligodendrogliopathy--multiple system atrophy.

Jonathan M Bleasel1,2, Glenda M Halliday1,2, Woojin Scott Kim3,4

  • 1Neuroscience Research Australia, Barker St, Randwick, Sydney, NSW, 2031, Australia.

Acta Neuropathologica Communications
|February 11, 2016
PubMed
Summary

Multiple system atrophy (MSA), a rare neurodegenerative disease, involves alpha-synuclein in oligodendrocytes. Animal models are crucial for understanding MSA pathogenesis and exploring new therapies.

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.7K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

21.1K

Related Experiment Videos

Last Updated: Mar 26, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.5K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.7K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

21.1K

Area of Science:

  • Neurodegenerative diseases
  • Oligodendrogliopathies
  • Neurobiology

Background:

  • Multiple system atrophy (MSA) is a rare, rapidly progressive neurodegenerative disorder.
  • Clinical presentation includes autonomic failure, parkinsonism, or cerebellar ataxia.
  • Unique neuropathology involves alpha-synuclein aggregates in oligodendrocytes (glial cytoplasmic inclusions).

Purpose of the Study:

  • To review and discuss animal models developed for MSA.
  • To explain how these models advance understanding of MSA pathogenesis, particularly alpha-synuclein aggregation.
  • To explore therapeutic avenues and future directions in MSA modeling.

Main Methods:

  • Review of existing literature on animal models for MSA.
  • Analysis of how these models elucidate MSA-specific pathological pathways.
  • Examination of studies utilizing animal models for therapeutic target identification.

Main Results:

  • Animal models have been instrumental in delineating unique MSA pathological pathways.
  • These models aid in understanding the dynamics of alpha-synuclein aggregation in oligodendrocytes.
  • Studies using animal models have informed clinical phenotyping and therapeutic strategies.

Conclusions:

  • Animal models are vital for studying the early pathogenesis of MSA.
  • They offer insights into the unique oligodendroglial pathology of MSA.
  • Future MSA modeling holds promise for developing effective treatments.